Journal of Preventive Medicine and Public Health

The Korean Society for Preventive Medicine (대한예방의학회)
권호 표지

Therapeutic Compliance and Its Related Factors of Lung Cancer Patients

폐암환자의 치료순응도와 관련요인

  • Kam, Sin (Department of Preventive Medicine and Public Health, School of Medicine, Kyungpook National University) ;
  • Park, Jae-Yong (Department of Internal Medicine, School of Medicine, Kyungpook National University) ;
  • Chae, Sang-Chul (Department of Internal Medicine, School of Medicine, Kyungpook National University) ;
  • Bae, Moon-Seob (Department of Internal Medicine, School of Medicine, Kyungpook National University) ;
  • Shin, Moo-Chul (Department of Internal Medicine, School of Medicine, Kyungpook National University) ;
  • Yeh, Min-Hae (Department of Preventive Medicine and Public Health, School of Medicine, Kyungpook National University) ;
  • Nam, Si-Hyun (Department of Preventive Medicine and Public Health, School of Medicine, Kyungpook National University)
  • 감신 (경북대학교 의과대학 예방의학교실) ;
  • 박재용 (경북대학교 의과대학 내과학교실) ;
  • 채상철 (경북대학교 의과대학 내과학교실) ;
  • 배문섭 (경북대학교 의과대학 내과학교실) ;
  • 신무철 (경북대학교 의과대학 내과학교실) ;
  • 예민해 (경북대학교 의과대학 예방의학교실) ;
  • 남시현 (경북대학교 의과대학 예방의학교실)
  • Published : 2002.03.01
Download PDF
⟨ Previous Next ⟩

Abstract

Objectives : To investigate the therapeutic compliance and its related factors in lung cancer patients. Methods : The subjects of this study comprised 277 patients first diagnosed with lung cancer at Kyungpook National University Hospital between Jan 1999 and Sept 1999. Of these, 141(50.9%) participated in the study by properly replying to structured questionnaires. The data was analyzed using a simplified Health Decision Model. This model includes categories of variables covering therapeutic compliance, health beliefs, patient preferences, knowledge and experience, social interaction, sociodemographic and clinical characteristics. Results : The therapeutic compliance rate of the 141 study subjects was 78.0%. An analysis of health beliefs and patient preferences revealed health concern (p<0.05), dependency on medicine (p<0.05), perceived susceptibility and severity (p<0.05) as well as preferred treatment (p<0.01) as factors related to therapeutic compliance. Factors from the sociodemographic characteristics and clinical factors that were related to therapeutic compliance were age (p<0.01), monthly income (p<0.05), histological type (p<0.05) and clinical stage (p<0.05) of cancer. Conclusions : In order to improve therapeutic compliance in lung cancer patients it is necessary to educate the aged, low-income patients, or patients who have small cell lung cancer or lune cancer of an advanced stage for which surgery is not indicated. Additionally, it is essential for medical personnel to have a deep concern about patients who have poor lifestyles, a low dependency on medicine, or a high perceived susceptibility and severity. Practically, early diagnosis of lung cancer and thoughtful considerations of low-income patients are important. By means of population-based education in a community, we may promote attention to health and enhance the early diagnosis of lung cancer.

Keywords

References

  1. Mendelsohn J. Principles of neoplasia. In: Isselbacher KJ, editors. Harrison's Principles of Internal Medicine. 13th ed.New York: McGraw-Hill, Inc.; 1994. p. 1814-26
  2. Wingo PA, Tong T, Bolden S. Cancer statistics. CA 1995; 45: 8-30 re-cited[14] https://doi.org/10.3322/canjclin.45.1.8
  3. Minna JD. Neoplasms of the lung. In: Isselbacher KJ, editors. Harrison's Principles of Internal Medicine. 13th ed. New York: McGraw-Hill, Inc.; 1994. p. 1221-9
  4. Wingo PA, Ries LA, Giovino GA et al. Annual report to the nation on the status of cancer, 1973-1996, with a special section on lung cancer and tobacco smoking [see comments]. J Natl Cancer Inst 1999; 91: 675-90 https://doi.org/10.1093/jnci/91.8.675
  5. Kim SY, Ohrr H, Kang HG, Kim SI, Yi SW. Cancer incidence in Kangwha county. Korean J Prev Med 1999; 32(4): 482-490 (Korean)
  6. National Statistical Office. Annual Report on the Cause of Death Statistics, 1998 (Korean)
  7. Fielding JE, Husten CG, Eriksen MP. Tobacco: Health effects and control. In: Wallace RB, editors. Maxcy-Rosenau-Last Public Health and Preventive Medicine. 14th ed. Stamford: Appleton & Lange; 1998. p.817-45
  8. National Statistical Office. Social Indicators in Korea, 1998 (Korean)
  9. Kim HJ, Jeong MP, Heo DS et al. Lung cancer in Korea(1980년-1984). Korean J Med 1994; 46: 221-8 (Korean)
  10. Kim JS, Chae SC, Shin MC et al. Recent trend of lung cancer. Korean J Med 1997; 53: S114 (Korean)
  11. Ministry of Health and Welfare. Report on Cancer Registry Data Analysis(1993. 1.1.-1993. 12. 31), 1995 (Korean)
  12. Jeong EK, Tak YJ, Song YM et al. A comparison of reminder models for increasing compliance for cervical cancer screening in a family practice setting. J Korean Fam Med 1992; 13(2): 117-124 (Korean)
  13. Lee KS, Koo HW, Lee WJ, Chang SH, Yoo KY. Factors associated with the use of Pap test in a rural area. Korean J Prev Med 1999; 32(2): 147-54 (Korean)
  14. Chae SC, Park JY, Kim JS et al. Factors influencing the therapeutic compliance of patients with lung cancer. Tuber Resp Dis 1998; 45(5): 953-961 (Korean) https://doi.org/10.4046/trd.1998.45.5.953
  15. Eraker SA, Kirscht JP, Becker MH. Understanding and improving patient compliance. Annals Internal Medicine 1984; 100: 258-68
  16. Seeman M, Evans JW. Alienation and socialleaming in a reformatory. Am J Soc 1962; 69: 270-84
  17. Shaheen JA, Amin M, Harty n. Patient compliance in treatment of prostate cancer with luteinizing hormone-releasing hormone (LHRH) agonist. Urology 1993; 42: 533-5 https://doi.org/10.1016/0090-4295(93)90265-C
  18. Kim JH, Choi EK, Chang H et al. Postoperative adjuvant MVP chemothe-rapy and radiotherapy for non-small cell lung cancer. J Korean Soc Ther Radiol 1995; 13(2): 149-156 (Korean)
  19. Choi EK, Kim JH, Chang H et al. Hyper-fractionated radiotherapy and concurrent chemotherapy for stage III unresectable non small cell lung cancer: preliminary report for response and toxicity. J Korean Soc Ther Radio1 1995; 13(2): 157-62
  20. Lee CR, Nicholson PW, Souhami RL et al. Patient compliance with prolonged low-dose oral etoposide for small cell lung cancer. Br J Cancer 1993; 67(3): 630-4 https://doi.org/10.1038/bjc.1993.115
  21. Berger D, Braverman A, Sohn CK, Morrow M. Patient compliance with aggressive multirnodal therapy in locally advanced breast cancer. Cancer 1988; 61(7): 1453-6 https://doi.org/10.1002/1097-0142(19880401)61:7<1453::AID-CNCR2820610729>3.0.CO;2-#
  22. Ayres A, Hoon PW, Franzoni JB et al. Influence of mood and adjustment to cancer on compliance with chemotherapy among breast cancer patients. J Psychosom Res 1994; 38: 393-402 https://doi.org/10.1016/0022-3999(94)90100-7
  23. Cathcart CS, Dunican A, Halpern IN. Patterns of delivery of radiation therapy in an inner-city population of head and neck cancer patients: an analysis of compliance and end results. J Med 1997; 28(5-6): 275-84
  24. Park KS, Chun BY, Kam S et al. Structural relationships among health concern, health practice and health status of the disabled. Korean J Prev Med 1999; 32(3): 276-288 (Korean)
  25. Gochman DS, Saucier JF. Perceived vulnerability in children and adolescents. Educ Q 1982; 9(2-3): 142-55
  26. Greenberg ER, Chute CG, Stukel T et al. Social and economic factors in the choice of lung cancer treatment. N Engl J Med 1988; 318: 612-7 https://doi.org/10.1056/NEJM198803103181006
  27. Berg JW, Ross R, Latourette HB, Economic status and survival of cancer patients. Cancer 1977; 39: 467-77 https://doi.org/10.1002/1097-0142(197702)39:2<467::AID-CNCR2820390215>3.0.CO;2-B
  28. Cella DF, Orav EJ, Komblith AB et al. Socioeconomic status and cancer survival. J Clin Onco1 1991; 9(8): 1500-9 https://doi.org/10.1200/JCO.1991.9.8.1500
  29. McWhorter WP, Schatzkin AG, Horm JW, Brown CC. Contribution of socioeconomic status to black/white differences in cancer incidence. Cancer 1989;63(5):982-7 https://doi.org/10.1002/1097-0142(19890301)63:5<982::AID-CNCR2820630533>3.0.CO;2-I
  30. Young BJ, Bultz BD, Russell JA, Trew MS. Compliance with follow-up of patients treated for non-seminomatous testicular cancer. Br J Cancer 1991; 64: 606-8 https://doi.org/10.1038/bjc.1991.359
  31. Hussey JP, Gilliland K. Compliance, low literacy and locus of control. Nursing Clinics North America 1989; 24(3): 605-11
  32. Becker MH, Maiman LA. Strategies for enhancing patient compliance. J Community Health 1980; 6: 113-35 https://doi.org/10.1007/BF01318980
  33. Cramer JA. Optimizing long-term patient compliance. Neurology 1995;45: S25-8
  34. Morisky DE, Levine DM, Green LW et al. Five-year blood pressure control and mortality following health education for hypertensive patients. Am J Public Health 1983; 73: 153-62 https://doi.org/10.2105/AJPH.73.2.153
  35. Leffell DJ, Berwick M, Bolognia J. The effect of pre-education on patient compliance with full-body examination in a public skin cancer screening. J Dermatol Surg Onco1 1993; 19: 660-3 https://doi.org/10.1111/j.1524-4725.1993.tb00407.x
  36. Stimson GV. Obeying doctor's orders: a view from the other side. Social Science and Medicine 1974; 8: 97-104 https://doi.org/10.1016/0037-7856(74)90039-0
  37. Cameron K, Gregor F. Chronic illness and compliance. J Advanced Nursing 1987; 12(6): 671-6 https://doi.org/10.1111/j.1365-2648.1987.tb01368.x
  38. Ross FM. Patient compliance-whose responsibility? Soc SciMed 1991; 32: 89-94
  39. Morris LS, Schulz RM. Patient com-pliancean overview. J Clin Pharm Ther 1992; 17: 283-95 https://doi.org/10.1111/j.1365-2710.1992.tb01306.x
  40. Peteet JR, Stomper PC, Ross DM et al. Emotional support for patients with cancer who are undergoing CT: semistructured interviews of patients at a cancer institute. Radiology 1992; 182: 99-102 https://doi.org/10.1148/radiology.182.1.1727318
  41. Roethlisberger FJ, Dickson WJ, Wright HA. Management and the Worker. Cambridge:MA; 1946
  42. Becker MH, Drachman RH, Kirscht JP. Predicting mothers' compliance with pediatric medical regimens. J Pediatr 1972;81: 843-54
  43. Roh GH, Cho YA. Compliance of patching therapy for amblyopia. J Korean Ophthalmol 1993; 34(11): 1171-117 (Korean)
  44. Kim SS. Lee YS. Chun BY. Factors associated with the compliance and the treatment efficiency in patients with pulmonary tuberculosis. J Korean Pub Health 1992; 37: 130-141 (Korean)
  45. Kim CT, Lee KS, Kang PS. Factors influencing compliance with anti-tuberculosis therapy.Korean J Prev Med 1996;29(1): 79-90 (Korean)